Tower Research Capital (TRC)’s PepperLime Health Acquisition Corporation Class A Ordinary Share PEPL Stock Holding History
Bought
Maintained
Sold
Other funds holding PEPL
PAMP
RCM
SCM
RCM
HCM
CSS
ACM
Tower Research Capital (TRC)'s PEPL Position: Q3 2022 in Review
Tower Research Capital (TRC) sold out of PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) in Q3 2022, closing a stake of 83 shares — an estimated $1K sold.
Tower Research Capital (TRC) first reported a position in PEPL in Q4 2021 and held it in 3 quarters. The position peaked at $1K in Q2 2022. 43 funds tracked by Wall St. Rank hold PEPL as of Q3 2022.
- Tower Research Capital (TRC) reported no remaining PepperLime Health Acquisition Corporation Class A Ordinary Share position as of Q3 2022 after selling out during the quarter.
- Tower Research Capital (TRC) sold 83 PepperLime Health Acquisition Corporation Class A Ordinary Share shares in Q3 2022, an estimated $1K.
- Tower Research Capital (TRC) first reported a position in PepperLime Health Acquisition Corporation Class A Ordinary Share in Q4 2021 and held it in 3 quarters.
- Tower Research Capital (TRC)'s PepperLime Health Acquisition Corporation Class A Ordinary Share position peaked at $1K in Q2 2022.
- 43 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Class A Ordinary Share as of Q3 2022.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.